RUSCONI, STEFANO

RUSCONI, STEFANO  

Dipartimento di Scienze Biomediche e Cliniche  

Mostra records
Risultati 1 - 20 di 312 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
11th European AIDS Conference, Madrid, Spain, 24-27 October 2007 1-gen-2007 Rusconi S. Article (author) -
13th Conference on Retroviruses and Opportunistic Infections (CROI),DENVER, USA, 5-8 1-gen-2006 Rusconi S. Article (author) -
14th conference on retroviruses and opportunistic infections, Los Angeles, CA, USA, 25-28 february 2007 1-gen-2007 Rusconi S. Article (author) -
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study 1-gen-2020 Giacomelli, AndreaBernacchia, DarioSiano, MatteoBonazzetti, CeciliaCovizzi, AliceSchiuma, MarcoPasserini, MatteoPiscaglia, MarcoBrambilla, Anna MariaRiva, AgostinoTorre, AlessandroRusconi, StefanoAntinor, SpinelloGalli, Massimo + Article (author) -
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 2-gen-2020 Di Cristo, ValentinaVitiello, PaolaCossu, Maria VittoriaColella, ElisaRusconi, Stefano + Article (author) -
A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215 1-gen-2000 S. RusconiS. La Seta Catamancio + Article (author) -
Abacavir hypersensitivity reaction after switching from the twice-daily to the once-daily formulation 1-gen-2007 O. ViganoE. GianelliM. OrtuM. GalliS. Rusconi + Article (author) -
Absence of new thymidine-associated mutations and evidence of an immune virologic response over a 12-month period in a cohort of antiretroviral- experienced HIV-1-infected subjects treated with tenofovir combination therapy [2] 1-ott-2005 M. Lo CiceroO. ViganòP. CicconiM. GalliS. Rusconi + Article (author) -
Accessibility to SARS-CoV-2 swab test during the Covid-19 pandemic : Did age make the difference? 1-dic-2021 Sojic A.Giacomelli A.Rusconi S.Pagani G.Galli M.Prinelli F. + Article (author) -
Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects 1-feb-2002 S. RusconiE. BulgheroniS. La Seta-CatamancioF.G. CroceM. Lo CiceroP.M. CitterioM. Galli Article (author) -
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 1-gen-2020 Benetti E.Asselta R.Furini S.Seri M.Nigro V.Tartaglia M.Sara A.Palmieri M.D'Alessandro M.Feri M.Scala R.Donati A.D'Arminio Monforte A.Merlini E.Rusconi S.Siano M.Gabrieli A.Riva A.Parisi S. G.Magro P.Carella M.Meloni I.Mandala M.Fiorentino G.Menatti E.Baratti S.Pinto A. M. + Article (author) -
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection 1-gen-2021 Montefusco, LauraBen Nasr, MoufidaD'Addio, FrancescaLoretelli, CristianAbdelsalam, AhmedMaestroni, AnnaDell'Acqua, MarcoIppolito, ElioAssi, EmmaUsuelli, VeraSeelam, Andy JoeMorpurgo, PaolaLunati, Maria ElenaRusconi, StefanoRiva, AgostinoSantus, PierachilleNebuloni, ManuelaFolli, FrancoZuccotti, Gian VincenzoGalli, MassimoFiorina, Paolo + Article (author) -
AIDS in a long-term HIV-1-infected patient with a stable high CD4+ cell count and conserved CD4+CD45RO+ subpopulation 1-dic-1996 S. RusconiA. GoriC. RivaC. BalottaM. Galli + Article (author) -
Alovudine Medivir 1-feb-2003 S. Rusconi Article (author) -
Altered signaling lymphocytic activation molecule (SLAM) expression in HIV infection and redirection of HIV-specific responses via SLAM triggering 1-set-1999 M. BiasinS. RusconiM. GalliM. Clerici + Article (author) -
Alternating versus continuous drug regimens in combination chemotherapy of human immunodeficiency virus type 1 infection in vitro 1-apr-1994 S. Rusconi + Article (author) -
Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferation 1-lug-1999 S. RusconiS. La Seta-CatamancioM. GalazziD. TrabattoniM. GalliM. Clerici + Article (author) -
An update in the development of HIV entry inhibitors 1-gen-2007 S. Rusconi + Article (author) -
Analysis of protease inhibitor combinations in vitro : activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates 1-mar-2004 E. BulgheroniP. CitterioF. CroceM. Lo CiceroO. ViganòM. GalliS. Rusconi + Article (author) -
Analysis of the env V3 sequences obtained from patients with HIV type 1 infection treated with the immune modulant agent tucaresol 1-set-2005 A. BanderaM. GalliA. GoriS. Rusconi + Article (author) -